Active antisense oligonucleotides directed against the insulin-like growth factor type I receptor (IGF-IR/AS ODN) have shown potential as an antitumour agent in animal studies. In April Journal of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback